NovoCure Ltd. (NVCR) PT Raised to $74 at Wells Fargo
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Price: $15.26 +2.83%
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 21
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 21
Join SI Premium – FREE
Wells Fargo analyst Larry Biegelsen raised the price target on NovoCure Ltd. (NASDAQ: NVCR) to $74.00 (from $70.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- First Solar (FSLR) PT Lowered to $196 at Jefferies
- Texas Roadhouse (TXRH) PT Raised to $235 at UBS Ahead of Q2 Earnings
- First Business Financial (FBIZ) PT Raised to $80 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
